Year To Quarter End Statement Of Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Year to quarter end statement of income
Statement of income
Net sales
1,068,000,000 JPY
88,330,000,000 JPY
5,985,000,000 JPY
75,299,000,000 JPY
11,395,000,000 JPY
75,299,000,000 JPY
93,749,000,000 JPY
63,348,000,000 JPY
63,348,000,000 JPY
10,511,000,000 JPY
4,915,000,000 JPY
75,579,000,000 JPY
983,000,000 JPY
79,758,000,000 JPY
Cost of sales
44,265,000,000 JPY
35,750,000,000 JPY
30,469,000,000 JPY
38,238,000,000 JPY
Gross profit (loss)
44,065,000,000 JPY
39,548,000,000 JPY
32,878,000,000 JPY
37,341,000,000 JPY
Selling, general and administrative expenses
38,291,000,000 JPY
34,863,000,000 JPY
30,251,000,000 JPY
33,324,000,000 JPY
Selling, general and administrative expenses
Depreciation
3,094,000,000 JPY
3,066,000,000 JPY
2,910,000,000 JPY
2,917,000,000 JPY
Operating profit (loss)
99,000,000 JPY
5,773,000,000 JPY
460,000,000 JPY
4,684,000,000 JPY
636,000,000 JPY
4,684,000,000 JPY
5,881,000,000 JPY
2,627,000,000 JPY
2,627,000,000 JPY
1,064,000,000 JPY
261,000,000 JPY
4,017,000,000 JPY
81,000,000 JPY
4,035,000,000 JPY
Non-operating income
Interest income
57,000,000 JPY
21,000,000 JPY
Dividend income
1,392,000,000 JPY
1,297,000,000 JPY
Gain on sale of securities
JPY
JPY
585,000,000 JPY
585,000,000 JPY
Non-operating income
1,542,000,000 JPY
1,594,000,000 JPY
2,396,000,000 JPY
2,329,000,000 JPY
Non-operating expenses
Interest expenses
21,000,000 JPY
13,000,000 JPY
10,000,000 JPY
18,000,000 JPY
Non-operating expenses
341,000,000 JPY
385,000,000 JPY
248,000,000 JPY
203,000,000 JPY
Ordinary profit (loss)
6,974,000,000 JPY
5,893,000,000 JPY
4,776,000,000 JPY
6,142,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
6,000,000 JPY
5,000,000 JPY
121,000,000 JPY
121,000,000 JPY
Extraordinary income
12,033,000,000 JPY
12,033,000,000 JPY
8,349,000,000 JPY
8,349,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
0 JPY
0 JPY
JPY
JPY
Impairment losses
2,895,000,000 JPY
2,895,000,000 JPY
2,895,000,000 JPY
JPY
JPY
Extraordinary losses
3,398,000,000 JPY
3,106,000,000 JPY
43,000,000 JPY
43,000,000 JPY
Profit (loss) before income taxes
15,610,000,000 JPY
14,820,000,000 JPY
13,082,000,000 JPY
14,449,000,000 JPY
Income taxes - current
2,918,000,000 JPY
2,611,000,000 JPY
2,819,000,000 JPY
3,263,000,000 JPY
Income taxes - deferred
716,000,000 JPY
671,000,000 JPY
-44,000,000 JPY
-104,000,000 JPY
Income taxes
3,634,000,000 JPY
3,282,000,000 JPY
2,774,000,000 JPY
3,159,000,000 JPY
Profit (loss)
11,538,000,000 JPY
11,975,000,000 JPY
11,538,000,000 JPY
11,538,000,000 JPY
11,538,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
11,289,000,000 JPY
10,307,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.